Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

       
Total article views   HTML views PDF downloads Totals
12,771 Dovepress* 10,655+ 1,205 11,860
PubMed Central* 2,116 393 2,509
Totals 12,771 1,598 14,369
*Since 11 October 2017

View citations on PubMed Central and Google Scholar